gefitinib (ZD1839)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for gefitinib (ZD1839), covering 2010-07-20 to 2014-08-11. Get the full timeline:
Most recent: Clinical Trial Update: ZD1839 With Hypofractionated Radiation Therapy With an Immobilization Device for Advanced Non-Small Cell Lung Cancer [Phase 1]